Like girls, U.S. boys may be hitting puberty earlier (Reuters, 20 October 2012)

Novo Nordisk wins EU agency backing for new insulin (Reuters, 19 October 2012)

European regulators reject Vivus obesity drug (Reuters, 18 October 2012)

22 Oct 2012

The European Medicines Agency has recommended against approval of the marketing application for Vivus' obesity drug Qsiva (phentermine/topiramate).

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read